Results 161 to 170 of about 73,026 (266)

PHACE syndrome with severe aortic arch tortuosity: a case report. [PDF]

Eur Heart J Case Rep
Masuda Y, Ogino K, Hayashi T, Waki K.
europepmc   +1 more source

Aortic arch anomalies

The Journal of Thoracic and Cardiovascular Surgery, 1970
R L, Hewitt, P L, Brewer, T, Drapanas
openaire   +2 more sources

Proton arc therapy reduces the dose delivered to circulating blood compared to intensity‐modulated proton therapy for head‐and‐neck cancer

Journal of Applied Clinical Medical Physics, Volume 27, Issue 11, November 2026.
Background Compared to intensity‐modulated proton therapy (IMPT), proton arc therapy (PAT) has various dosimetric advantages. However, questions have been raised over whether the larger low‐dose bath during PAT may increase radiation‐induced lymphocyte killing, which is correlated with adverse clinical outcomes.
Sebastian Tattenberg, Peilin Liu, Xiaoda Cong, Cornelia Hoehr, Xuanfeng Ding   +4 more
wiley   +1 more source

Clinical Features, Treatments, and Outcomes of an International Cohort of 96 Children with Takayasu Arteritis

ACR Open Rheumatology, Volume 8, Issue 11, November 2026.
Objective To characterize the clinical features, treatment, and outcomes of a large, international cohort of childhood‐onset Takayasu arteritis (cTAK). Methods Patients with a diagnosis of cTAK were identified in A Registry of Childhood Vasculitis and divided into subcohorts by era‐of diagnosis: pre‐biologic (PB; 1986–2006), early biologic (EB; 2007 ...
James Bistolarides, Kimberly A. Morishita, Vidya Sivaraman, Linda Wagner‐Weiner, Else S. Bosman, Nick McPhate, James J. Nocton, Melodee Liegl, Amy Y. Pan, Michael W. Beresford, Sirirat Charuvanij, Marietta de Guzman, Melissa Elder, Teresa Giani, Samuel Gagne, Katie Harrison, Karen James, Marija Jelusic, Archana Khan, Neil Martin, Jonathan Park, Alan M. Rosenberg, Susan Shenoi, Tamara Tanner, Stacey E. Tarvin, Marinka Twilt, Rae S. M. Yeung, Kelly Brown, David Cabral, for the ARCHiVe Investigators Network within the PedVas Initiative and the CARRA Chronic Childhood Vasculitis workgroup   +29 more
wiley   +1 more source

Endovascular technology for aortic arch repair: from innovation to integration. [PDF]

Ann Cardiothorac Surg
Nauta FJH, van Sambeeck PS, Saouti N, Jenniskens S, Dirven M, Heijmen RH.   +5 more
europepmc   +1 more source

Resection of the Aortic Arch

Annals of Surgery, 1958
W S, CONKLIN, J T, GRISMER, J A, AALPOEL
openaire   +3 more sources

Plaque‐Hepatic Targeting Nanotherapy Disrupts the PCSK9‐LOX‐1 Axis to Suppress oxLDL in Atherosclerosis

Advanced Science, Volume 13, Issue 61, 3 November 2026.
Self‑amplifying PCSK9–LOX‑1 feedback axis drives atherosclerotic progression by promoting oxLDL generation and endothelial uptake. A dual‑targeting nanoplatform (siPCSK9@PEAL NPs‑aL) is constructed to simultaneously silence hepatic PCSK9 for lipid lowering and block plaque LOX‑1 for anti‑inflammation.
Yi Duan, Yijie Qiu, Yan Zhu, Quan Wang, Jiangtao Lin, Yourong Duan, Qi Wang, Yi Dong   +7 more
wiley   +1 more source

The Endovascular Treatment of Aortic Arch Pathologies. [PDF]

Dtsch Arztebl Int
Kunzmann S, Kondov SK, Schlett CL, Lescan M, Czerny M, Kreibich M.   +5 more
europepmc   +1 more source

Interrupted aortic arch

The Journal of Thoracic and Cardiovascular Surgery, 1984
openaire   +2 more sources

Epicardial adipose tissue‐linked leukotriene and cytokine signalling pathways – novel targets for prevention of obesity‐ and diabetes‐linked ventricular arrhythmia

The Journal of Physiology, EarlyView.
Kelly A. Aromolaran, Ademuyiwa S. Aromolaran   +1 more
wiley   +1 more source